Patents by Inventor Yan Lagouge

Yan Lagouge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
    Patent number: 7250410
    Abstract: The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: July 31, 2007
    Assignee: Via Pharmaceuticals, Inc.
    Inventors: Jean-Jacques Bourguignon, Yan Lagouge, Claire Lugnier, Eveline Klotz, Jean-Paul Macher, Pierre Raboisson, Dominique Schultz
  • Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
    Publication number: 20060128695
    Abstract: The invention concerns the use of PDE2 inhibitors for treating disorders of the central and peripheral nervous system, a method for therapeutic treatment by administering to an animal said inhibitors. More specifically, the invention concerns novel benzodiazepinone derivatives and their uses in therapeutics more particularly for treating pathologies involving activity of a cyclic nucleotide phosphodiesterase type 2. The invention also concerns methods for preparing same and novel synthesis intermediates.
    Type: Application
    Filed: October 30, 2003
    Publication date: June 15, 2006
    Applicants: NEURO3D, UNIVERSITE LOUIS PASTEUR
    Inventors: Jean-Jacques Bourguignon, Claire Lugnier, Mustapha Abarghaz, Yan Lagouge, Patrick Wagner, Cesare Mondadori, Jean-Paul Macher, Dominique Schultz, Pierre Raboisson
  • Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
    Publication number: 20040152888
    Abstract: The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates.
    Type: Application
    Filed: November 26, 2003
    Publication date: August 5, 2004
    Inventors: Jean-Jacques Bourguignon, Yan Lagouge, Claire Lugnier, Eveline Klotz, Jean-Paul Macher, Pierre Raboisson, Dominique Schultz